Generated by All in One SEO v4.9.4.1, this is an llms.txt file, used by LLMs to index the site.

# Ponce Aurora

Introducing Yuuth™ - The First Cosmetics For The Digital Age

## Sitemaps

- [XML Sitemap](https://ponceaurora.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses](https://ponceaurora.com/pulmatrix-picked-for-reverse-merger-with-anti-aging-biotech-weeks-after-cullgen-deal-collapses/) - Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses
- [Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan](https://ponceaurora.com/pulmatrix-and-eos-senolytix-announce-merger-agreement-to-advance-novel-mitochondrial-therapies-to-improve-healthspan/) - Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan PRN Newswire Release • Combined company to operate as Eos SENOLYTIX, a first-in-class anti-aging biotechnology company • $19 million financings to advance lead clinical candidate PTC-2105 for sarcopenia and age-related disease FRAMINGHAM, MA and HOUSTON, TX — March 26, 2026
- [Pulmatrix and Eos merge to advance gerotherapeutics](https://ponceaurora.com/pulmatrix-and-eos-merge-to-advance-gerotherapeutics/) - Pulmatrix and Eos merge to advance gerotherapeutics
- [Brent Saunders Appointed as Advisory Board Chairman](https://ponceaurora.com/brent-saunders-appointed-as-advisory-board-chairman/) - Saunders was previously CEO of Allergan, the company that developed and launched Botox™ until the company’s $63 billion acquisition by AbbVie Inc. in 2020 Miami, FL – February 26, 2025 9:00 a.m. Eastern – Eos SENOLYTIX, Inc., a company leveraging the growing scientific knowledge surrounding the aging process to develop “anti-aging” gerotherapeutics that may improve health
- [Ponce Aurora Appoints Former Estee Lauder Executive as Chief Commercial Officer Ahead of Longevity Product Launches](https://ponceaurora.com/ponce-aurora-appoints-former-estee-lauder-executive-as-chief-commercial-officer-ahead-of-longevity-product-launches/) - Ponce Aurora is developing consumer products powered by its proprietary MitoXcel™ Technology, the first information- and AI-driven mitochondrial-targeted geropeptides addressing a fundamental cause of aging. Appointment strengthens leadership team to drive market readiness for YUUTH- and MitoX-branded product launches planned for later this year. “Together, Anna and Hélène anchor a growing leadership team as we strive to build the iconic longevity

## Pages

- [Ponce Aurora](https://ponceaurora.com/) - Ponce Aurora - Introducing Yuuth™ - The First Cosmetics For The Digital Age - Powered by MitoXcel™ Technology
- [Company](https://ponceaurora.com/company/) - Our Leadership MANAGEMENTBOARD OF DIRECTORSCLINICAL ADVISORY BOARDSCIENTIFIC ADVISORY BOARD Kevin Slawin, MDChairman and CEOKevin Slawin, M.D. is the Founder and Managing Partner of Rapha Capital Management, LLC. Formerly a robotic oncologic surgeon, he is now a biotech investor and founder focusing on disruptive healthcare technologies. He was the founder of Bellicum Pharmaceuticals, Inc., leading Bellicum
- [Corporate Contact](https://ponceaurora.com/corporate-contact/) - Contact Us First name Last name Your email Subject Your message Ponce Aurora An Affiliate of GEROTHERAPEUTIX, Inc. 2710 Reed Road, Suite 160 Houston, TX 77051 Email: info@ponceaurora.com
- [Product Pipeline](https://ponceaurora.com/pipeline/) - Product Pipeline
- [Media Center](https://ponceaurora.com/media-center/) - Media Center Press ReleasesNews March 26, 2026 in News, Press Releases Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan PRN Newswire Release • Combined company to operate as Eos SENOLYTIX, a first-in-class anti-aging
- [Product](https://ponceaurora.com/product-yuuth-full-body-treatment/)
- [Collections](https://ponceaurora.com/collections/)
- [Events & Presentations](https://ponceaurora.com/events-presentations/) - Events & Presentations Upcoming Presentations Past Presentations 2nd Annual Obesity & Cardiometabolic Innovation Forum (#Sachs_OCIF) 06/05/2026 Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX Read More » INNOCOS BEAUTY, TECH & LONGEVITY SUMMIT 02/18/2026 February 18-20, 2026 - Hayes Mansion San Jose, Curio Collection by Hilton, San Jose, California INNOCOS BEAUTY, TECH & LONGEVITY SUMMIT:
- [Terms of service](https://ponceaurora.com/terms-of-service/) - Terms of service These Terms of Use (“Terms”) apply to and govern your access and use of the website ponceaurora.com, and the information and services made available at the website. These Services are solely intended to providing general information and are not intended to provide medical advice of any kind. Please read these Terms carefully
- [Privacy Policy](https://ponceaurora.com/privacy-policy-2/) - Privacy Policy Ponce Aurora Online Privacy NoticeThis Privacy Notice (“Notice”) describes how Ponce Aurora (“Ponce Aurora”, “we”, “our” or “us”) collects and processes personal information online through ponceaurora.com and all other Ponce Aurora websites and applications (the “Services”) that link to this Notice. Personal Information That We Collect Personal information is information, or a combination
- [Cart](https://ponceaurora.com/cart/) - [shopify_cart]
- [Form Test](https://ponceaurora.com/form-test/)
- [PrintOrgans OD](https://ponceaurora.com/printorgans-od/) - PrintOrgans On Demand is a Joint Venture collaboration between PrintBio and the Wake Forest Institute for Regenerative Medicine (WFIRM), combining forces to develop 3D printed organs “on demand”. PrintOrgans On Demand brings together two leading teams in the field of regenerative medicine, in a collaborative effort that will combine complimentary areas of expertise in ways
- [Products](https://ponceaurora.com/products/) - Our Products PrintBio has developed unique capabilities, materials and technologies that enable the creation of living tissue implants for therapeutic applications. Leveraging this materials science, regulatory and clinical experience, PrintBio is preparing to launch its first two products that provide physicians with unprecedented capabilities in managing their patients. 3DMatrix™ 3D-printed monofilament bioresorbable surgical mesh (pending
- [Science and Technology](https://ponceaurora.com/science-and-technology/) - Our Platform PrintBio has developed unique capabilities, materials and technologies that enable the creation of living tissue implants for therapeutic applications. The PrintBio technology platform is unique because it creates living tissue implants with exceptional performance and was purpose-built to meet the FDA’s requirements for therapeutic manufacturing. The platform includes novel and proprietary 3D-bioprinter (GMPrint™),
- [Sample Page](https://ponceaurora.com/sample-page/) - This is an example page. It's different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: Hi there! I'm a bike messenger
- [Terms of Use](https://ponceaurora.com/terms-of-use/) - Terms of Use Agreement Between User and senothera.wpenginepowered.com and ir.senothera.wpenginepowered.com Welcome to senothera.wpenginepowered.com and ir.senothera.wpenginepowered.com. The senothera.wpenginepowered.com and ir.senothera.wpenginepowered.com website (the “Site”) is comprised of various web pages operated by PrintBio, Inc.. senothera.wpenginepowered.com and ir.senothera.wpenginepowered.com is offered to you conditioned on your acceptance without modification of the terms, conditions, and notices contained herein (the “Terms”).
- [Privacy Policy](https://ponceaurora.com/privacy-policy/) - Privacy Policy Protecting your private information is our priority. This Statement of Privacy applies to PrintBio, Inc. and governs data collection and usage. For the purposes of this Privacy Policy, unless otherwise noted, all references to PrintBio, Inc. include https://senothera.wpenginepowered.com/ and https://ir.senothera.wpenginepowered.com/. PrintBio, Inc. website is an informational website. By using PrintBio, Inc. website, you
- [Patients](https://ponceaurora.com/patients/) - PATIENTS Revolutionizing the standard of care for patients across multiple life changing programs Our Vision Our vision is to repair or replace human tissues and organs, that are individually designed for each patient. We aim to treat a wide range of conditions, from congenital to traumatic, as well as injuries subsequent to degeneration and cancer.

## My Templates

- [Elementor Loop Item #782](https://ponceaurora.com/?elementor_library=elementor-loop-item-782) - Elementor Loop Item #782 Read More »
- [Elementor Single Post #790](https://ponceaurora.com/?elementor_library=elementor-single-post-790) - Elementor Single Post #790 Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses PrevPreviousElementor Archive #768 NextElementor Loop Item #782Next
- [Elementor Archive #768](https://ponceaurora.com/?elementor_library=elementor-archive-768) - Elementor Archive #768 Shop All About Us Product Pipeline Events & Presentations Media Center Contact Us Shop All About Us Product Pipeline Events & Presentations Media Center Contact Us Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses March 27, 2026 Read More » Pulmatrix and Eos merge to advance gerotherapeutics
- [Default Kit](https://ponceaurora.com/?elementor_library=default-kit)

## Events and Presentations

- [2nd Annual Obesity & Cardiometabolic Innovation Forum (#Sachs_OCIF)](https://ponceaurora.com/events-and-presentat/2nd-annual-obesity-cardiometabolic-innovation-forum-sachs_ocif/) - Platform Technologies Panel: Obesity & Cardiovascular-Kidney-Metabolic Disease Kevin Slawin, M.D., Founder and CEO Eos SENOLYTIX Dr. Slawin will also give a 20-minute presentation in Track B that begins at 1:45 pm CST
- [INNOCOS BEAUTY, TECH & LONGEVITY SUMMIT](https://ponceaurora.com/events-and-presentat/innocos-beauty-tech-longevity-summit/)
- [Beauty Longevity Summit](https://ponceaurora.com/events-and-presentat/beauty-longevity-summit/)

## Categories

- [News](https://ponceaurora.com/category/news/)
- [Press Releases](https://ponceaurora.com/category/press-releases/)

## Tags

- [Press Releases](https://ponceaurora.com/tag/press-releases/)
- [News](https://ponceaurora.com/tag/news/)